Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT

Fig. 2

Outcomes of r/r aggressive B-cell lymphoma cases according to TP53 alteration status after CAR19/22 T-cell infusion. a Best responses in r/r aggressive B-cell lymphoma cases with or without TP53 alterations. Kaplan–Meier analysis of DOR (b), PFS (c), and OS (d) in r/r aggressive B-cell lymphoma cases on the basis of TP53 alteration status. ORR, objective response rate; OR objective response; CR complete response; PR partial response; SD stable disease; DOR duration of response; W/O without

Back to article page